Malignant Hypertension,Adrenal Hyperplasia and Depletion of Potassium

Abstract

Get full access to this article

View all access options for this article.

References

Aubertin

Ambard

(1904). Lésions des capsules surrénales dans les néphrites avec hypertension. Bull. Soc. méd. Hôp. Paris, 21, 175.

Buchem

F. S. P.

Van. Door Enbos

Elings

H. S.

(1956). Primary aldosteronism due to adrenocortical hyperplasia. Lancet, 2, 335.

Conn

(1956). Aldosterone in clinical medicine: Past, present, future. Arch. int. Med., 97, 135.

Dawson

I. M. P.

(1956). Changes in the adrenal cortex in essential and renal hypertension. J. Path. Bact., 72, 393.

Edelman

I. S.

Olney

J. M.

James

A. H.

Brooks

Moore

F. D.

(1952). Body composition : Studies in the human being by the dilution principle. Science, 115, 447.

Garrod

Nabarro

J. D. N.

Pawan

G. L. S.

Walker

(1955). Metabolic effects of 9α-fluoro hydrocortisone and of cortisone in adrenal insufficiency. Lancet, 2, 367.

Holten

Petersen

V. P.

(1956). Malignant hypertension with increased secretion of aldosterone and depletion of potassium. Lancet, 2, 918.

Mokotoff

Ross

Letter

(1952). The electrolyte content of skeletal muscle in congestive heart failure; a comparison of results with inulin and chloride as reference standards for extracellular water. J. clin. Invest., 31, 291.

Thomas

(1910). Ueber Veraenderungen der Nebennieren insbesondore bei Schrumpfniere. Beitr. path. Anat., 49, 228.

10.

Wyngaarden

J. B.

Keitel

H. G.

Isselbacher

(1954). Potassium depletion and alkalosis: Their association with hypertension and renal insufficiency. New Engl. J. Med., 250, 597.